Dr. Philips’ research focuses on identifying biomarkers that guide the development of personalized therapies to improve treatment precision and patient outcomes. With a multidisciplinary background in pharmacy, pharmacogenomics, bioinformatics, and business administration, he brings integrated expertise to solving key challenges and advancing progress in precision medicine.
His research spans multiple domains and has consistently focused on developing pipelines to identify biomarkers that predict therapeutic response. Building on this foundation, his current research applies deep learning and integrative multi-omics analyses that combine clinical, genomic, and immunological data to uncover predictors of response to cancer immunotherapies, particularly checkpoint inhibitors. Through this comprehensive approach, he aims to unravel tumor–immune interactions and drive the development of more effective, personalized cancer treatments.
M.B.A. - Indiana University, Indianapolis, IN 2024
Ph.D. - Indiana University Luddy School of Informatics, Computing, and Engineering, Indianapolis, IN 2016
M.S. - Indiana University Luddy School of Informatics, Computing, Engineering, Indianapolis, IN 2004
Pharm.D. - Ramaiah College of Pharmacy, Bangalore, India 1999
